PRELOAD PRELOAD PRELOAD PRELOAD PRELOAD

Content on this page requires a newer version of Adobe Flash Player.

Get Adobe Flash player

With four products on the market and a fully-integrated multinational organization in place, BioMarin is providing innovative therapeutics to patients with serious unmet medical needs.

LATEST NEWS

  • BioMarin Pharmaceutical Inc. Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)...  MORE >
  • BioMarin Announces BMN-673 Data in Breast and Ovarian Cancers to be Released at ASCO...  MORE >
  • BioMarin to Present at the UBS Global Healthcare Conference...  MORE >